Aptevo Therapeutics Inc (NASDAQ:APVO)
| 1.76 Delayed Data As of 3:59pm ET |  0.00 / 0.00%Today’s Change | 1.65 Today|||52-Week Range 7.20 | -24.14% Year-to-Date |
Latest APVO News | Press Releases
No recent news for Aptevo Therapeutics Inc.
Today’s Trading
| Previous close | 1.76 |
| Today’s open | 1.78 |
| Day’s range | 1.76 - 1.78 |
| Volume | 198 |
| Average volume (3 months) | 565,819 |
| Market cap | $10.9M |
Data as of 3:59pm ET, 03/21/2023
Growth & Valuation
| Earnings growth (last year) | +35.85% |
| Earnings growth (this year) | +114.83% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +185.26% |
| P/E ratio | 1.6 |
| Price/Sales | 3.00 |
| Price/Book | 8.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CANFCan Fite Biopharma L... | +0.04 | +1.83% |
| VBLTVascular Biogenics L... | +0.01 | +8.53% |
| HMTXFHemostemix Inc | -0.01 | -6.64% |
| IMNNImunon Inc | +0.04 | +3.03% |
Data as of 3:59pm ET, 03/21/2023
Financials
| Next reporting date | March 29, 2023 |
| EPS forecast (this quarter) | -$1.53 |
| Annual revenue (last year) | $12.3M |
| Annual profit (last year) | -$28.5M |
| Net profit margin | -239.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
